CCR2 and neoplasm: Given our data on how CCR2 gene deletion reduced MDSC and Treg infiltration and increased intratumoral accumulation of activated CD8+ T cells (Figure 3), we undertook a corresponding analysis of cells present within the tumor microenvironment of WT mice receiving vehicle or CCR2 antagonist therapy.